GoodRx Holdings, Inc.(GDRX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,339 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
GDRX Stock Analysis & AI Quality Score
AI stock analysis and institutional research for GoodRx Holdings, Inc. (GDRX), a Technology sector company. 13F Pro's AI-powered ranking engine scores GDRX at 52.5/100 on a 32-signal composite quality model, placing it at rank #1,339 of 2,879 stocks — the top half of the AI-ranked universe. GDRX scores in the top quartile across free cash flow (76.2), earnings quality (75.0). Areas of concern include institutional flow (16.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 17.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), GoodRx Holdings, Inc. reports quarterly revenue of $194.0M, net income of $1.2M, an operating margin of 7.2%. Top institutional holders of GDRX by reported 13-F value include Francisco Partners Management,, AMERIPRISE FINANCIAL, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. GDRX trades on the Nasdaq exchange and files with the SEC under CIK 1809519. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GDRX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GoodRx Holdings, Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$194.0M
Net Income
Q1 2026
$1.2M
Free Cash Flow
Q1 2026
$10.7M
Operating Margin
Q1 2026
7.2%
ROIC
Q1 2026
1.3%
D/E Ratio
Q1 2026
0.78
Get alerted when GDRX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for GoodRx Holdings, Inc. including:
Top Institutional Holders of GDRX
Francisco Partners Management, LP
$117.8M60,078,184 shAMERIPRISE FINANCIAL INC
$8.7M4,455,760 shVANGUARD CAPITAL MANAGEMENT LLC
$8.4M4,261,516 shSilver Lake Group, L.L.C.
$6.9M3,532,276 shVANGUARD PORTFOLIO MANAGEMENT LLC
$6.6M3,362,864 shRENAISSANCE TECHNOLOGIES LLC
$6.4M3,259,738 shPetrus Trust Company, LTA
$6.1M3,098,559 shDIMENSIONAL FUND ADVISORS LP
$4.8M2,451,141 shPRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
$4.1M2,105,502 shBlackRock, Inc.
$3.6M1,861,591 sh
| Fund | Value | Shares |
|---|---|---|
| Francisco Partners Management, LP | $117.8M | 60,078,184 |
| AMERIPRISE FINANCIAL INC | $8.7M | 4,455,760 |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.4M | 4,261,516 |
| Silver Lake Group, L.L.C. | $6.9M | 3,532,276 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.6M | 3,362,864 |
| RENAISSANCE TECHNOLOGIES LLC | $6.4M | 3,259,738 |
| Petrus Trust Company, LTA | $6.1M | 3,098,559 |
| DIMENSIONAL FUND ADVISORS LP | $4.8M | 2,451,141 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | $4.1M | 2,105,502 |
| BlackRock, Inc. | $3.6M | 1,861,591 |
More Technology Companies
View all Technology →Put GDRX on your watchlist
Track score changes the day GoodRx Holdings, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is GDRX a good stock to buy?
13F Pro's AI-powered analysis of GoodRx Holdings, Inc. (GDRX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GDRX are available on the GDRX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own GDRX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GDRX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of GoodRx Holdings, Inc.'s investment landscape.